Edition:
United States

Sientra Inc (SIEN.OQ)

SIEN.OQ on NASDAQ Stock Exchange Global Select Market

19.74USD
19 Jul 2018
Change (% chg)

-- (--)
Prev Close
$19.74
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
163,945
52-wk High
$21.30
52-wk Low
$8.79

Select another date:

Wed, May 9 2018

BRIEF-Sientra Q1 Loss Per Share $0.99

* Q1 EARNINGS PER SHARE VIEW $-0.84 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

BRIEF-Sientra Inc. Announces Closing Of $115 Mln Public Offering Of Common Stock

* SIENTRA, INC. ANNOUNCES CLOSING OF $115 MILLION PUBLIC OFFERING OF COMMON STOCK AND EXERCISE IN FULL OF UNDERWRITERS’ OVER-ALLOTMENT OPTION Source text for Eikon: Further company coverage:

BRIEF-Sientra Announces Pricing Of Upsized Public Offering Of Common Stock

* SIENTRA ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING OF COMMON STOCK

BRIEF-Sientra Inc Says Commenced Underwritten Public Follow-On Offering Of About $75 Mln Of Its Stock To Be Sold By Co

* SIENTRA INC - COMMENCED UNDERWRITTEN PUBLIC FOLLOW-ON OFFERING OF ABOUT $75 MILLION OF ITS STOCK TO BE SOLD BY COMPANY

BRIEF-Sientra Sees Preliminary Unaudited Net Sales For Q1 2018 Of About $14.5 Mln

* SIENTRA INC - SEES PRELIMINARY UNAUDITED NET SALES FOR Q1 2018 OF ABOUT $14.5 MILLION

BRIEF-Sientra Receives FDA Approval Of PMA Supplement

* SIENTRA INC - ADDITIONAL $10 MILLION OF EXISTING CREDIT FACILITY NOW ACCESSIBLE WITH FDA APPROVAL

BRIEF-Sientra Says Reached An Agreement-In-Principle With Staff Of Division Of Enforcement Of U.S. SEC

* SIENTRA INC - REACHED AN AGREEMENT-IN-PRINCIPLE WITH STAFF OF DIVISION OF ENFORCEMENT OF U.S. SECURITIES AND EXCHANGE COMMISSION - SEC FILING

BRIEF-Sientra Reports Qtrly Loss Per Share $0.92

* SIENTRA REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

BRIEF-Sientra Says Co Enters Into Agreement With Stifel, Nicolaus & Co Inc

* SIENTRA SAYS CO ENTERED INTO AGREEMENT WITH STIFEL, NICOLAUS & CO INC, TO SELL SHARES OF STOCK HAVING AN OFFERING PRICE OF UP TO $50 MILLION- SEC FILING Source text for Eikon: Further company coverage:

BRIEF-Sientra Provides Update On FDA Review Of U.S. Manufacturing Facility

* SIENTRA® PROVIDES UPDATE ON FDA REVIEW OF U.S. MANUFACTURING FACILITY

Select another date: